AZGP1 and colorectal carcinoma: As shown in Figure 1A, serum ZAG levels in NW + CRC patients were 11.7% higher than in healthy controls (1.53 ± 0.30 vs. 1.37 ± 0.31 μg/mL, P < 0.05).